References
- SobelJDVaginitisN Engl J Med199733726189619039407158
- MandellGLBennettJEDolinRMandellGLBennettJEDolinRMandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases6th EdPhiladelphia, PAElsevier20053656
- FredricksDNFiedlerTLThomasKKOakleyBBMarrazzoJMTargeted PCR for detection of vaginal bacteria associated with bacterial vaginosisJ Clin Microbiol200745103270327617687006
- KasperDLBraunwaldEHauserSLongoDJamesonJLFauciASHarrison’s Principle of Internal Medicine16th EdNew York, NYMcGraw-Hill2005
- BoggessKATrevettTNMadianosPNUse of DNA hybridization to detect vaginal pathogens associated with bacterial vaginosis among asymptomatic pregnant womenAm J Obstet Gynecol20051933 Pt 175275616150270
- LivengoodCH3rdFerrisDGWiesenfeldHCEffectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trialObstet Gynecol20071102 Pt 130230917666604
- StepanCSurawiczCMTreatment strategies for C. difficile associated diarrheaActa Gastroenterol Latinoam200737318319117955730
- ShenBFazioVWRemziFHCombined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitisDis Colon Rectum200750449850817279300
- KiserJDPaulsonCPBrownCClinical inquiries. What’s the most effective treatment for giardiasis?J Fam Pract200857427027218394362
- JodlowskiTZLamSAshbyCRJrEmerging therapies for the treatment of Helicobacter pylori infectionsAnn Pharmacother200842111621163918845620
- FungHBDoanTLTinidazole: a nitroimidazole antiprotozoal agentClin Ther200527121859188416507373
- MattilaJMännistöPTMäntyläRNykänenSLamminsivuUComparative pharmacokinetics of metronidazole and tinidazole as influenced by administration routeAntimicrob Agents Chemother19832357217256870221
- LampKCFreemanCDKlutmanNELacyMKPharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobialsClin Pharmacokinet199936535337310384859
- JokipiiAMMyllyläVVHokkanenEJokipiiLPenetration of the blood brain barrier by metronidazole and tinidazoleJ Antimicrob Chemother197733239245873873
- WoodBAFaulknerJKMonroAMThe pharmacokinetics, metabolism and tissue distribution of tinidazoleJ Antimicrob Chemother198210Suppl A43577118775
- LiXQBjörkmanAAnderssonTBGustafssonLLMasimirembwaCMIdentification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro dataEur J Clin Pharmacol20035956429442
- BerganTSolhaugJHSøreideOLeinebøOComparative pharmacokinetics of metronidazole and tinidazole and their tissue penetrationScand J Gastroenterol19852089459504081633
- AustinMNMeynLAHillierSLSuspectibility of vaginal bacteria to metronidazole and tinidazoleAnaerobe2006125–622723016893662
- EkgrenJNorlingBKDegreMMidtvedtTComparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosisGynecol Obstet Invest19882643133173068098
- HeikkinenJVuopalaSAnaerobic vaginosis: treatment with tinidazole vaginal tabletsGynecol Obstet Invest1989282981002792920
- VutyavanichTPongsuthirakPVannareumolPRuangsriRALuangsookPA randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosisObstet Gynecol1993824 Pt 15505548377981
- MilaniMBarcellonaEAgnelloAEfficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trialEur J Obstet Gynecol Reprod Biol20031091677112818447
- BaylsonFANyirjesyPWeitzMVTreatment of recurrent bacterial vaginosis with tinidazoleObstet Gynecol20041045 Pt 193193215516381